Literature DB >> 27765762

MicroRNA-29c regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts.

Shingo Matsushima1, Junichi Ishiyama2.   

Abstract

MicroRNAs play an important role in the development and progression of various diseases, such as idiopathic pulmonary fibrosis (IPF). Although the accumulation of aberrant fibroblasts resistant to apoptosis is a hallmark in IPF lungs, the mechanism regulating apoptosis susceptibility is not fully understood. Here, we investigated the role of miR-29, which is the most downregulated microRNA in IPF lungs and is also known as a regulator of extracellular matrix (ECM), in the mechanism of apoptosis resistance. We found that functional inhibition of miR-29c caused resistance to Fas-mediated apoptosis in lung fibroblasts. Furthermore, experiments using miR-29c inhibitor and miR-29c mimic revealed that miR-29c regulated expression of the death receptor, Fas, and formation of death-inducing signaling complex leading to extrinsic apoptosis. The representative profibrotic transforming growth factor (TGF)-β downregulated the expression of miR-29c as well as Fas receptor and conferred resistance to apoptosis. We also found that introduction of miR-29c mimic abrogated these TGF-β-induced phenotypes of Fas repression and apoptosis resistance. The results presented here suggest that downregulation of miR-29 observed in IPF lungs may be associated with the apoptosis-resistant phenotype of IPF lung fibroblasts via downregulation of Fas receptor. Therefore, restoration of miR-29 expression in IPF lungs could not only inhibit the accumulation of ECM but also normalize the sensitivity to apoptosis in lung fibroblasts, which may be an effective strategy for treatment of IPF.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  Fas; TGF-β; apoptosis resistance; fibrosis; miR-29

Mesh:

Substances:

Year:  2016        PMID: 27765762     DOI: 10.1152/ajplung.00252.2016

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  14 in total

Review 1.  Mechanisms for the Resolution of Organ Fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Physiology (Bethesda)       Date:  2019-01-01

2.  MicroRNA-29c Prevents Pulmonary Fibrosis by Regulating Epithelial Cell Renewal and Apoptosis.

Authors:  Ting Xie; Jiurong Liang; Yan Geng; Ningshan Liu; Adrianne Kurkciyan; Vrishika Kulur; Dong Leng; Nan Deng; Zhenqiu Liu; Jianbo Song; Peter Chen; Paul W Noble; Dianhua Jiang
Journal:  Am J Respir Cell Mol Biol       Date:  2017-12       Impact factor: 6.914

Review 3.  Role of MicroRNAs in Signaling Pathways Associated with the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Focus on Epithelial-Mesenchymal Transition.

Authors:  Ana Ruth Cadena-Suárez; Hilda Arely Hernández-Hernández; Noé Alvarado-Vásquez; Claudia Rangel-Escareño; Bettina Sommer; María Cristina Negrete-García
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

Review 4.  The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.

Authors:  Aline Fastrès; Florence Felice; Elodie Roels; Catherine Moermans; Jean-Louis Corhay; Fabrice Bureau; Renaud Louis; Cécile Clercx; Julien Guiot
Journal:  Int J Mol Sci       Date:  2017-12-16       Impact factor: 5.923

5.  Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.

Authors:  Lanzhi Zhang; Rui Zhou; Weibin Zhang; Xueqing Yao; Weidong Li; Lijun Xu; Xuegang Sun; Liang Zhao
Journal:  J Exp Clin Cancer Res       Date:  2019-03-08

Review 6.  miRNAs in Lung Development and Diseases.

Authors:  Eistine Boateng; Susanne Krauss-Etschmann
Journal:  Int J Mol Sci       Date:  2020-04-16       Impact factor: 5.923

7.  Astragaloside IV Synergizing with Ferulic Acid Ameliorates Pulmonary Fibrosis by TGF-β1/Smad3 Signaling.

Authors:  Jiahuan Tong; Zhisong Wu; Yuchen Wang; Qingxun Hao; Haoge Liu; Fang Cao; Yang Jiao
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-02       Impact factor: 2.629

8.  Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli.

Authors:  Amos E Dodi; Iyabode O Ajayi; Christine Chang; Meghan Beard; Shanna L Ashley; Steven K Huang; Victor J Thannickal; Daniel J Tschumperlin; Thomas H Sisson; Jeffrey C Horowitz
Journal:  Respir Res       Date:  2018-05-10

Review 9.  Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis.

Authors:  Thị Hằng Giang Phan; Panagiotis Paliogiannis; Gheyath K Nasrallah; Roberta Giordo; Ali Hussein Eid; Alessandro Giuseppe Fois; Angelo Zinellu; Arduino Aleksander Mangoni; Gianfranco Pintus
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

Review 10.  More than a Genetic Code: Epigenetics of Lung Fibrosis.

Authors:  Krystian Bartczak; Adam J Białas; Mateusz J Kotecki; Paweł Górski; Wojciech J Piotrowski
Journal:  Mol Diagn Ther       Date:  2020-12       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.